Current setbacks cannot prevent gene-editing companies from advancing closer to “one-and-done” cures and new products.

About 150 people in Singapore have transthyretin amyloid cardiomyopathy. Read more at straitstimes.com. Read more at ...

The mood at the annual meeting of the American Society of Cell and Gene Therapy isn’t amazing. The biotech market has been ...

In a new study published in Cell Reports, researchers at the University of Freiburg reveal how a disordered protein segment ...

Danforth Technology Company launched Spearhead Bio to make the process of gene editing faster and more efficient.

Leading trade organizations representing the makers of cell and gene therapies are calling for a 10-year moratorium on ...

Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a ...

Stylus will use the Eli Lilly and J&J-backed funds to advance its in vivo genetic medicines platform and develop its pipeline ...

According to analysts at Grand View Research, the global genome market is expected to expand at a compound annual growth rate ...

While receiving treatment for a car accident ten years ago, Mr Chua learnt that he had an abnormal build-up of protein in his ...

Brussels has made an 11th hour gambit to get Britain to halt advanced work on gene editing crops, which would allow UK farmer ...

Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...